Comments
Commented by Fabian Lorenz on September 15th, 2025 | 07:20 CEST
Gold mining stocks in takeover fever! Barrick Mining and Newmont are selling! B2Gold neighbor Desert Gold in the crosshairs?
Takeover fever is sweeping through the gold sector. The typical cycle of the industry appears to be repeating itself once again: with the rising price of gold, which remains solidly above USD 3,600, the appetite for takeovers is also growing. Gold producers are earning more, and banks and private equity firms are opening their coffers for mergers and acquisitions. For large and small mining companies alike, the current market phase offers an opportunity to expand their portfolios, optimize projects, or reposition themselves through strategic sales and purchases. Barrick and Newmont are currently raising billions through asset sales, boosting their war chests. In contrast, Desert Gold - a neighbor of B2Gold - could soon see a partner come on board or even become an acquisition target. Analysts see significant upside potential for the share.
Read
Commented by Nico Popp on September 15th, 2025 | 07:15 CEST
No more diet injections! Innovations in weight loss drugs: BioNxt Solutions, Merck & Co., Novo Nordisk
As recently reported by the United Nations Children's Fund (UNICEF), for the first time, more children worldwide are obese than underweight. While this is a great success in the fight against hunger, it also poses new risks. Severe overweight in childhood leads to obesity and associated diseases in adulthood, such as cardiovascular problems and diabetes. The treatment of overweight and diabetes in children is therefore likely to play an even more significant role in the future. GLP-1 receptor agonists have been popular for several years now in the form of modern weight loss injections. With patents expiring soon, experts anticipate substantial further growth and development in this rapidly expanding market. We explain who could benefit and what the future holds for modern diet medications.
Read
Commented by Stefan Feulner on September 15th, 2025 | 07:10 CEST
Equinox Gold, AJN Resources, K92 Mining – Gold boom with clear signals
The price of gold is currently only moving in one direction: Steeply upwards! After jumping above the previous record high of USD 3,500 per ounce, the USD 4,000 mark is now within reach. Central banks are buying massively, and investors are seeking security amid geopolitical crises, thereby driving up prices. Gold mining stocks are now benefiting enormously from this development. We present three stocks that are particularly in focus and are being carried by the current momentum.
Read
Commented by Fabian Lorenz on September 15th, 2025 | 07:05 CEST
NATO without drone defense! Opportunity for Rheinmetall, DroneShield and Volatus Aerospace!
Is a new rally starting for drone stocks? The shooting down and crash of Russian drones in Poland has painfully highlighted NATO's vulnerability in this area. Recent years have shown how unmanned aerial vehicles are revolutionizing warfare. However, NATO appears to have a lot of catching up to do in terms of its drone inventory, detection and defense. Volatus Aerospace—which trains pilots and monitors borders, among other things—and drone defense specialist DroneShield should benefit from this. Both stocks had multiplied in value at the beginning of the summer. After the setback, prices could now rise again. Rheinmetall is also becoming increasingly involved in this area. What does Germany's largest defense contractor have to offer?
Read
Commented by André Will-Laudien on September 15th, 2025 | 07:00 CEST
Security is key – Acquisitions continue to drive growth! 100% bull market possible with Almonty, Steyr, Mutares and Deutz
The stock markets are looking for direction! While the Russia-Ukraine conflict enters the next round with the drone incident in Poland, prices for strategic metals continue to rise. Western industries are under pressure from NATO rearmament and are looking for secure jurisdictions to be able to process highly sensitive orders. Supplies of critical raw materials from China have fallen by 90% since March 2025, with only long-term contracts still being fulfilled. But what about the current boom in orders? The price of the critical metal tungsten has doubled within 12 months. The primary beneficiary is Almonty Industries, as it already has active mines in Europe and is about to launch a mega-project in South Korea. Highly exciting, but also a challenge for investors. What happens next?
Read
Commented by Fabian Lorenz on September 12th, 2025 | 07:15 CEST
200% shares Steyr Motors and PanGenomic Health! When will cancer-fighter BioNTech explode?
More than 200% price gains are not enough: Steyr Motors and PanGenomic Health continue to go full throttle. Despite its strong performance in recent weeks, PanGenomic still appears undervalued. With the use of artificial intelligence, the Canadians want to tap into the billion-dollar market for personalized alternative medicine and dietary supplements in North America. Their e-commerce platform has just gone live. Steyr Motors reports several successes in China, opening up a billion-dollar market for the Austrians. In contrast, BioNTech shares are not moving. Yet the Mainz-based company is increasingly becoming a real cancer fighter. Will the stock soon explode?
Read
Commented by André Will-Laudien on September 12th, 2025 | 07:10 CEST
Cryptos & tokens in rally mode - Caution with Strategy, Finexity, Coinbase and Palantir
Stock market dynamics evolve in certain cycles. With the advent of high-performance computers, trading has become faster, and new asset classes like cryptocurrencies are leading to a shift in liquidity to other segments. The global crypto market is expected to experience exponential growth through 2030, potentially reaching over EUR 10 trillion, driven by increasing acceptance of tokens, DeFi, NFTs, and institutional investments. The market opportunities for tokenized securities are enormous, with experts projecting an annual growth rate of over 60%. Strategy and Coinbase are very well-positioned on the NASDAQ as prominent representatives of the crypto sector. Palantir is proving to be an innovation leader at the interface of AI, Blockchain, and data management. In Germany, the financial services provider Finexity AG recently went public. Opportunities are plentiful – but selection is far from easy.
Read
Commented by Armin Schulz on September 12th, 2025 | 07:05 CEST
Investing in the future of medicine: A look at Novo Nordisk, NetraMark Holdings and Evotec
AI is completely transforming the pharmaceutical industry. Modern algorithms sift through vast amounts of data, identify promising therapeutic approaches, and advance drug development at record speed. This increase in efficiency is an absolute game changer. Not only does it save billions, but it also significantly increases success rates and catapults agile companies to the forefront. While cumbersome large corporations laboriously digitize their research departments, disruptive start-ups with innovative AI platforms are shaking up the market. It is precisely this dynamic that presents unique opportunities for investors, if they know how to decipher them. Today, we take a closer look at Danish pharmaceutical giant Novo Nordisk, AI specialist NetraMark Holdings, and German research service provider Evotec.
Read
Commented by Armin Schulz on September 12th, 2025 | 07:00 CEST
NATO attack!? How to IMMEDIATELY arm your portfolio with RENK Group, Antimony Resources and Deutz
The presence of Russian drones on Polish territory - a NATO member - marks a dangerous escalation in the security situation. With a swift ceasefire in Ukraine increasingly seeming a distant prospect, investors should refocus their attention on defense stocks. This new escalation is directly fueling demand for modern defense technology and opening up tangible opportunities for investors in specialized suppliers. Three companies that stand to benefit directly from this trend are RENK Group, Antimony Resources and Deutz.
Read
Commented by Fabian Lorenz on September 11th, 2025 | 07:20 CEST
Almonty set for TAKEOVER? RENK after 260% rally! D-Wave Quantum faces exciting weeks ahead!
Almonty is making headlines with takeover plans in the US – tungsten production on American soil could help solve one of the country's strategic problems. It is difficult to understand why the share price did not react more strongly to the Bloomberg interview. Analysts already see 50% upside potential for Almonty shares and a 2027 P/E ratio of 5. RENK has also impressed with a 260% rally and strong half-year figures. With a new, state-of-the-art transmission for light tracked vehicles, the MDAX company is positioning itself for autonomous military technology. The coming weeks are likely to be exciting for D-Wave. The quantum high-flyer is participating in numerous international conferences. These provide a stage for technological advances and new customer contacts and could catapult the stock out of its sideways movement.
Read